Oncologic outcomes in patients undergoing maximal or optimal cytoreductive surgery for Stage 3C serous ovarian, tubal or peritoneal carcinomas
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Obstetrics and Gynaecology"
DOI: 10.1080/01443615.2019.1634028
Abstract: Abstract The aim of this study was to evaluate overall survival (OS) and disease-free survival (DFS) of patients with Stage 3C serous ovarian, tubal and peritoneal carcinomas. A retrospective analysis of 111 patients who underwent… read more here.
Keywords: tubal peritoneal; optimal cytoreductive; cancer; ovarian tubal ... See more keywords
Relationship Between Neoadjuvant Chemotherapy and Log Odds of Positive Lymph Nodes and Their Prognostic Role in Advanced Ovarian Cancer Patients With Optimal Cytoreductive Surgery
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.878275
Abstract: Purpose To analyze the relationship between neoadjuvant chemotherapy (NACT) and log odds of positive lymph nodes (LODDS), as well as their prognostic role in advanced ovarian cancer (AOC) patients with optimal cytoreductive surgery. Patients and… read more here.
Keywords: relationship; optimal cytoreductive; log; patients optimal ... See more keywords
Predicting value of HE4 and CA125 markers for optimal cytoreductive surgery in ovarian cancer patients
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Translational Myology"
DOI: 10.4081/ejtm.2022.10671
Abstract: We conducted a cross-sectional study to evaluate the role of serum levels of CA125 and HE4 in predicting optimal cytoreductive surgery. Eligible women who had been diagnosed with ovarian cancer based on both clinical and… read more here.
Keywords: surgery; optimal cytoreductive; ovarian cancer; value he4 ... See more keywords